Toxicology & Substance Abuse

Benzodiazepines (BZO) One Step Rapid Drug Test Device (Urine)

Powered by NomoFlow™

Easy to use device format Rapid 5-minute results High sensitivity and specificity Built-in control line

The Benzodiazepines (BZO) One Step Rapid Drug Test Device is a rapid, qualitative immunoassay for the detection of Benzodiazepines in urine at a cutoff of 300 ng/mL.

A Foundation of Trust

Powered by NomoFlow™
CE
Marked
ISO 13485

Why Choose Our Benzodiazepines Test Device?

Our Benzodiazepines (BZO) test device offers a convenient and reliable method for detecting BZO use. The integrated design ensures ease of use, providing accurate results in just 5 minutes, making it an ideal tool for on-site drug screening.

Inside NomoFlow™: The Source of This Test's Superior Performance

The Benzodiazepines (BZO) One Step Rapid Drug Test Device demonstrates high accuracy in detecting Benzodiazepines in urine samples.

Clinical Performance Characteristics

Analyte Sensitivity (PPA) Specificity (NPA) Overall Agreement
Benzodiazepines (BZO) 95.8% (95% CI: 91.9% - 98.0%) 99.1% (95% CI: 96.2% - 99.8%) 97.5%

Relevant studies and publications will be available here soon.

Time to Result 5 minutes
Sample Type Urine
Cut-off 300 ng/mL
Kit Size 25 Tests/Kit
Storage Conditions 2-30u00b0C
Shelf Life 24 Months
Included Materials Test devices, Package insert
Required Materials (Not Included) Urine collection container, Timer
Certifications CE, ISO 13485

1

Collect Sample

Collect urine sample in a clean, dry container.

2

Apply Sample

Add 3 drops of urine sample to the sample well of the device.

3

Read Result

Read the result at 5 minutes. Do not interpret after 10 minutes.

Benzodiazepines (BZO) One Step Rapid Drug Test Device (Urine)

  • Catalog Number: DOA-BZOUD

Download product documents for detailed information.

Support

Frequently Asked Questions

Direct answers regarding clinical performance, workflow, and logistics.

The cutoff level for this Benzodiazepines test is 300 ng/mL.
Two lines indicate a negative result. One line at the control region indicates a presumptive positive result. Refer to the package insert.

Have more specific technical or clinical questions?

Connect with a Clinical Application Specialist

For Clinical Professionals

Integrate into a Complete Respiratory Workflow

This test is a key component of a broader strategy for managing respiratory outbreaks, optimizing resource allocation, and improving patient outcomes. See how it fits into a complete workflow solution.

Explore Workflow Solutions

For Strategic Partners

Inject the Power of NomoFlow™ into Your Brand

Build your brand on our foundation of verifiable reliability. Our platform is available for OEM/ODM partnerships, offering superior products with complete manufacturing transparency.

Discover Partnership Value

Take the Next Step Towards Verifiable Reliability

Equip your facility with diagnostic tools engineered for certainty. Select your path below to get started.

Experience the Difference

Request evaluation samples for your laboratory validation.

Request Samples

Clinical Consultation

Discuss workflow integration with an application specialist.

Contact Support

Commercial Partnership

Inquire about distribution or OEM/ODM opportunities.

Become a Partner